Rivas Will

Prospect · United States

DSN Software

2026-05-01

How to read this. This is Rivas Will's read on publicly observable signals — founder tenure, PE fund vintage, hiring patterns, acquisition posture. It is analysis, not insider information. If you are the founder and we have it wrong, write to Sam — the correction ships in the next update.

DSN Software is the leading practice management platform built for specialty dental practices in the United States. It serves oral surgeons, periodontists, endodontists, and multi-specialty dental groups with cloud-native software covering scheduling, EHR, imaging, billing, payments, and pharmacy integration. The company claims approximately 900 customers nationwide.

History and ownership

The company was founded in 1978 in Centralia, Washington, and operated as a bootstrapped, privately held business for 46 years. Its original product line carried distinct brands for each dental specialty: OMS-Exec (oral surgery), Perio-Exec (periodontics), Endo-Exec (endodontics), and Dental-Exec (general dentistry). These have since been unified under the DSN Cloud platform, hosted on AWS.

Sam Munakl became CEO in 2020. Munakl is also the founder and CEO of Cytek, a cybersecurity firm in Tulsa, Oklahoma. In 2018, he acquired the dental IT company Tech Evolutions (now Xceltek), which appears to have been his entry point into the dental software vertical. Munakl is not the original founder of DSN Software.

The most likely original founder is Jason Haymond. Yelp's local-business listing for software development near Centralia, WA names "Jason Haymond, Owner" against the DSN Software entry (Yelp: Software Development near Centralia, WA, retrieved 2026-04-30). The same Yelp page also lists a separate boutique firm — Haymond Technologies — operating in the same town, classified as IT Services / Computer Repair / Software Development. The pattern fits the typical small-town founder hand-off: Haymond ran DSN as a private business for ~42 years, sold to Munakl's holdco in 2020, and now operates a separate post-exit IT business in the same town. DSN's own Leadership Team page (re-fetched 2026-04-30) lists Sam Munakl as CEO, Krystle Fulton as Chief Product & Strategy Officer, Brian Lavigne as COO, Ben Bradley as President of OMS Billing Solutions, and four functional heads — no Haymond, no founder credit, consistent with a clean 2020 exit. Liquidity terms were never disclosed.

On September 24, 2024, DSN Software announced a strategic growth investment from Vertica Capital Partners, a New York-based growth equity firm managing over $1 billion in assets focused exclusively on mission-critical enterprise software. Deal terms were not disclosed. Philip Vorobeychik, Managing Director at Vertica, stated that DSN "has established itself as the leader in the specialty dental software market." Vertica's LP base includes software entrepreneurs, university endowments, charitable foundations, family offices, and pension funds.

On May 5, 2025, DSN acquired OMS Billing Solutions, a billing and revenue cycle management services provider for specialty dental practices. Vertica Capital also had OMS Billing Solutions in its portfolio according to PitchBook, suggesting this was an orchestrated tuck-in within the Vertica platform thesis.

Product and market position

DSN's current product suite includes:

The company differentiates on specialty dental focus. General dental PMS vendors (Dentrix/Henry Schein, Eaglesoft/Patterson, Open Dental) serve a broader market but lack the specialty-specific workflows DSN provides: surgical templates, referral tracking, medical-dental cross-coding for insurance, and implant inventory. Cloud-native competitors like Tab32, Curve Dental, and Archy (VC-backed, $45M+ raised) target general dentistry, not the oral surgery / periodontics niche.

DSN reports customer outcomes of 40% increase in administrative productivity and 15% increase in case acceptance, with approximately 9 months to positive ROI. Pricing is custom-quoted with unlimited devices per subscription.

ARR estimate

No revenue figures have been disclosed. With approximately 900 customers on cloud-native SaaS and specialty dental practices typically paying $500-$1,000/month for a full-stack PMS, I estimate ARR in the range of $5M-$10M. The OMS Billing Solutions RCM revenue could add $1M-$3M. Total ARR estimate: $8M at low confidence.

Exit signal assessment

Exit signal strength: 2 out of 5. Vertica Capital Partners invested only 18 months ago (September 2024) and is in active buy-and-build mode. The OMS Billing Solutions tuck-in five months later confirms the platform thesis. Vertica typically holds for 3-7 years, placing the exit window at approximately 2027-2031. The current phase is growth and consolidation, not exit preparation.

The more interesting signal is what DSN's PE backing tells us about the specialty dental sub-vertical: Vertica's $1B+ fund chose this niche as a platform investment, validating that specialty dental PMS is attractive to growth equity at this scale. Other specialty dental software companies (not yet PE-backed) could be either future Vertica/DSN tuck-in targets or independent exit candidates for competing PE firms following the same thesis.

CEO's prior-company pattern: operator-acquirer / serial holdco-builder

A buyer evaluating DSN should not read Sam Munakl as a founder-CEO with an exit incentive. Public records show Munakl operates three companies in parallel with zero documented liquidity events: Cytek Cybersecurity (Tulsa OK, founded by Munakl, still active), Xceltek (formerly Tech Evolutions, dental IT, acquired by Munakl in 2018, still active per the SCDA 2024 conference bio retrieved 2026-04-30), and DSN Software (acquired 2020, still active). The Vertica Capital recapitalization in September 2024 was a partial liquidity event for the prior Munakl-era equity, not an exit — Munakl remained CEO, OMS Billing Solutions tucked in eight months later, and DSN's own current leadership page lists him in the CEO seat with no announced succession.

This is a fourth class in the founder-prior-company taxonomy emerging across this week's TRAVERSEs: operator-acquirer. Distinct from (a) the PE-exit-prone founder who has sold a previous company, (b) the stewardship founder running family succession (Witmer at ProjectTeam), and (c) the first-time-founder, first-time-seller (Harper at Owner Insite). The operator-acquirer's prior-company outcome is neither sale nor succession nor first, but stack-and-hold — and the implication for a buyer is that a clean DSN-only auction is unlikely until Vertica's exit clock forces it. The most plausible 2027-2031 path is a Vertica-led process where Munakl receives a partial rollover and continues as CEO of the platform under the next sponsor, not a Munakl-driven sell-side mandate.

Signal 3 (corp-dev hire): dated null at 2026-04-30

DSN runs no public ATS / careers page that surfaces in standard SERP searches. The DSN leadership page (re-fetched 2026-04-30) shows two layers — four C-suite roles (CEO, CPSO Krystle Fulton, COO Brian Lavigne, OMS Billing President Ben Bradley) and four functional heads (Growth Isaac Shapot, Sales Kim Cannon, Support Chris King, Software Dev Manager Jesus Garcia). No Head of Corporate Development, VP M&A, or Director of Strategy. This is consistent with the buy-side function being run by Vertica directly — Philip Vorobeychik, Managing Director — rather than by DSN. Same caveat as ProjectTeam: at this employee count and PE structure, the absence of a public corp-dev posting is not evidence of inactivity; it is the lack of a measurement surface. Re-verify on the next refresh.

Signal 5 (sub-vertical M&A): no 2026 DSN tuck-in surfaced

A targeted SERP for "DSN Software" acquired OR acquires 2026 specialty dental tuck-in (1 paid call this update) returned no 2026 transaction. OMS Billing Solutions (May 2025) remains DSN's only Vertica-era acquisition. Pace: 1 tuck-in in 18 months — slower than the implicit Vertica platform thesis (which would suggest 2-3 tuck-ins by month 18 if the strategy were aggressive consolidation). Either the platform is in product-integration mode pre-cadence, or specialty dental is harder to roll up than Vertica modeled. Re-verify on the next refresh.

Signal 6 (press cadence): 7.5-month dated null since 9 September 2025

Direct fetch of DSN's press page on 2026-05-01 returned six published press releases. The most recent is 9 September 2025: "DSN Software to Unveil Four Groundbreaking AI Features at AAOMS 2025" (republished via CBS42 / EIN Presswire, ID 837489087) — DSN's own press feed confirms the dateline. No DSN press release has been published in the 7.5 months since. The bulk updated timestamps on every prior press post cluster in late September 2025, indicating a one-time CMS migration / rebrand pass rather than ongoing content velocity.

The 7.5-month press dated null is a directional signal, not a dating one. Two readings, neither dispositive on its own:

  1. Build-mode quiet — integrating OMS Billing Solutions (May 2025) and the AAOMS-debuted AI features into the DSN Cloud platform requires engineering focus, not external announcements. Consistent with month-19 of Vertica's typical 4-7 year hold.
  2. Pre-process quiet — companies in serious sale-process diligence often pause public-facing press to avoid pricing leaks. This is the lesser reading — Vertica's hold is too early for active sell-side prep.

Cross-prospect pattern note (DSN ↔ Curve ↔ TherapyNotes). DSN's September 2025 AAOMS announcement framed "Four Groundbreaking AI Features" — the same AI-on-vertical-workflow optic that Curve Dental pushed across six Q1 2026 launches (CurveAI, Pearl AI, Mango Voice AI, etc., per the 2026-04-17 Curve TRAVERSE) and the same optic that Descartes Systems Group is paying $28M up-front for at Idelic (AI-driven driver safety, 23 April 2026 — see buyers/descartes-systems-group.md). The pattern across three independent sub-verticals — dental specialty, dental general, trucking — is that bootstrapped or PE-backed VSaaS companies that ship a credible AI module before going to market clear at higher multiples. DSN's AAOMS AI feature ship is consistent with product-roadmap optics ahead of an eventual Vertica-led process, even if that process is still 2-4 years out.

Exit-signal strength held at 2/5 with sharper dated-null framing on press cadence and a cross-prospect AI-on-vertical-workflow pattern. The ratings move would be a Vertica disclosed second tuck-in, a Munakl public-posture shift, or a corp-dev hire surfacing on a public ATS. Re-verify on the next refresh (target 2026-05-15 to 2026-05-22 — three-week cycle-back per Signal 3 recurring null).

Key people

Open questions

Sources